Intensive oral care can reduce bloodstream infection with coagulase-negative staphylococci after neutrophil engraftment in allogeneic hematopoietic stem-cell transplantation

Support Care Cancer. 2022 Jan;30(1):475-485. doi: 10.1007/s00520-021-06447-8. Epub 2021 Jul 27.

Abstract

Purpose: Bloodstream infection (BSI) is a major complication of allogeneic hematopoietic stem-cell transplantation (allo-SCT). There are several causes of BSI; in particular, severe oral mucositis (OM) can induce BSI due to coagulase-negative staphylococci (CoNS). The OM severity may be reduced with intensive oral care. Thus, we evaluated whether the type of oral care affects the BSI incidence eventually.

Method: We performed retrospective analysis on 206 recipients who underwent allo-SCT from 2006 to 2017 at our institute. Intensive oral care by a dental specialist was performed for 111 recipients (intensive-care group) and self-oral care was performed by 95 recipients (self-care group). Incidence of BSI was assessed by type of the oral care, before neutrophil engraftment (pre-E-BSI) and after neutrophil engraftment (post-E-BSI) period until 180 days after allo-SCT.

Result: A total of 112 BSI occurred in 90 of the 206 recipients and 120 bacteria were identified, with CoNS being the most prevalent. There was no significant difference in the incidence of pre-E-BSI between the self-care and intensive-care groups (30.8% and 30.6%, respectively; P = 0.508). Meanwhile, the incidence of post-E-BSI was significantly lower in the intensive-care group than in the self-care group (14.3% and 28.6%; P = 0.008). In addition, the intensive-care group had significantly lower incidence of post-E-BSI with CoNS than the self-care group (8.5% and 21.5%, respectively; P = 0.009).

Conclusion: Intensive oral care through the period of allo-HCT can significantly reduce the post-E-BSI occurrence, especially due to CoNS.

Keywords: Blood stream infection; Hematopoietic stem-cell transplantation; Neutrophil engraftment; Oral care; Oral mucositis.

MeSH terms

  • Bacteremia* / epidemiology
  • Bacteremia* / etiology
  • Bacteremia* / prevention & control
  • Coagulase
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Neutrophils
  • Retrospective Studies
  • Risk Factors
  • Sepsis*
  • Transplantation, Homologous

Substances

  • Coagulase